CAS: 1131345-14-6
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Etoricoxib-d4 REF: TM-T11246CAS: 1131345-14-6 | 98% | To inquire | Tue 07 Jan 25 | |
Etoricoxib-d4 REF: TR-E568909CAS: 1131345-14-6 | - - - | 13,329.00 € | Tue 11 Feb 25 | |
Etoricoxib D4 REF: 3D-GVB34514CAS: 1131345-14-6 | Min. 95% | To inquire | Wed 12 Feb 25 |
Etoricoxib-d4
CAS:1131345-14-6
Etoricoxib D4: COX-2 selective inhibitor; oral; IC50: COX-2 1.1 μM, COX-1 116 μM; deuterium-labeled.
Formula:
C18H11D4ClN2O2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
362.87
Ref: TM-T11246
1mg | 325.00 € | ||
5mg | 908.00 € | ||
10mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Etoricoxib-d4
Controlled ProductCAS:1131345-14-6
Formula:
C18D4H11ClN2O2S
Color and Shape:
Neat
Molecular weight:
362.867
Ref: TR-E568909
100mg | 13,329.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
Etoricoxib D4
CAS:1131345-14-6
Etoricoxib D4 is an antineoplastic drug that inhibits the growth of tumor cells. It is …
Formula:
C18H11D4ClN2O2S
Purity:
Min. 95%
Molecular weight:
362.87 g/mol
Ref: 3D-GVB34514
1mg | To inquire | ||
2mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire |
Estimated delivery in United States, on Wednesday 12 Feb 2025